A new blueprint for obesity care: does structure beat standard treatment?
Disease control
Recruiting now
This study tests whether a structured, multidisciplinary obesity care program—which may include the weight-loss drug semaglutide—helps adults with obesity lose more weight than usual care. Adults aged 18-65 with a BMI of 30 or higher will be followed for 18 months to see if they …
Sponsor: University of Health Sciences, Algeria • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC